BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 28276713)

  • 1. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
    Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
    Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen Sulfide Reduces Myeloid-Derived Suppressor Cell-Mediated Inflammatory Response in a Model of
    De Cicco P; Sanders T; Cirino G; Maloy KJ; Ianaro A
    Front Immunol; 2018; 9():499. PubMed ID: 29636751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis.
    Guan Q; Moreno S; Qing G; Weiss CR; Lu L; Bernstein CN; Warrington RJ; Ma Y; Peng Z
    J Leukoc Biol; 2013 Oct; 94(4):803-11. PubMed ID: 23901119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
    Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
    Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis.
    Iacobaeus E; Douagi I; Jitschin R; Marcusson-Ståhl M; Andrén AT; Gavin C; Lefsihane K; Davies LC; Mougiakakos D; Kadri N; Le Blanc K
    Immunol Cell Biol; 2018 Sep; 96(8):820-830. PubMed ID: 29569304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
    Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
    Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of experimental mouse models of inflammatory bowel disease.
    Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
    Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes.
    Casacuberta-Serra S; Parés M; Golbano A; Coves E; Espejo C; Barquinero J
    Immunol Cell Biol; 2017 Jul; 95(6):538-548. PubMed ID: 28108746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques.
    Sui Y; Frey B; Wang Y; Billeskov R; Kulkarni S; McKinnon K; Rourke T; Fritts L; Miller CJ; Berzofsky JA
    PLoS Pathog; 2017 May; 13(5):e1006395. PubMed ID: 28498847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated NKT cells facilitated functional switch of myeloid-derived suppressor cells at inflammation sites in fulminant hepatitis mice.
    Wu D; Shi Y; Wang C; Chen H; Liu Q; Liu J; Zhang L; Wu Y; Xia D
    Immunobiology; 2017 Feb; 222(2):440-449. PubMed ID: 27523745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
    Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
    Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD14
    Bernsmeier C; Triantafyllou E; Brenig R; Lebosse FJ; Singanayagam A; Patel VC; Pop OT; Khamri W; Nathwani R; Tidswell R; Weston CJ; Adams DH; Thursz MR; Wendon JA; Antoniades CG
    Gut; 2018 Jun; 67(6):1155-1167. PubMed ID: 28592438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.
    Park MY; Lim BG; Kim SY; Sohn HJ; Kim S; Kim TG
    Front Immunol; 2019; 10():183. PubMed ID: 30863394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
    Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
    Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus.
    Park MJ; Baek JA; Choi JW; Jang SG; Kim DS; Park SH; Cho ML; Kwok SK
    Front Immunol; 2021; 12():606024. PubMed ID: 33986739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory Effect of Urine-derived Stem Cells on Inflammatory Bowel Diseases via Downregulating Th1/Th17 Immune Responses in a PGE2-dependent Manner.
    Zhou C; Wu XR; Liu HS; Liu XH; Liu GH; Zheng XB; Hu T; Liang ZX; He XW; Wu XJ; Smith LC; Zhang Y; Lan P
    J Crohns Colitis; 2020 Jun; 14(5):654-668. PubMed ID: 31841595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-18Rα-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness.
    Holmkvist P; Pool L; Hägerbrand K; Agace WW; Rivollier A
    Eur J Immunol; 2016 Jun; 46(6):1371-82. PubMed ID: 27062602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.
    Papadaki MA; Aggouraki D; Vetsika EK; Xenidis N; Kallergi G; Kotsakis A; Georgoulias V
    Anticancer Res; 2021 Feb; 41(2):661-670. PubMed ID: 33517270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice.
    Foks AC; Van Puijvelde GH; Wolbert J; Kröner MJ; Frodermann V; Van Der Heijden T; Van Santbrink PJ; Boon L; Bot I; Kuiper J
    Cardiovasc Res; 2016 Aug; 111(3):252-61. PubMed ID: 27234908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.